Literature DB >> 10604751

Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury.

K L Newell1, P Boyer, E Gomez-Tortosa, W Hobbs, E T Hedley-Whyte, J P Vonsattel, B T Hyman.   

Abstract

The primary neuroaxonal dystrophies (NAD), which include infantile NAD and Hallervorden-Spatz syndrome (HSS), are characterized by dystrophic terminal axons and axonal swellings. Lewy bodies have been found in some cases. In Parkinson disease (PD) and dementia with Lewy bodies (DLB), Lewy bodies and neurites display prominent alpha-synuclein immunoreactivity. We examined 2 cases of HSS and 4 cases of infantile NAD with alpha-synuclein immunohistochemistry to test the hypothesis that these disorders with similar morphological findings might share a biochemical phenotype. Furthermore, we compared them to 8 cases of secondary or physiologic NAD of various causes and 2 cases of recent traumatic head injury. Alpha-synuclein positive neuronal cytoplasmic inclusions, including Lewy bodies, and neurites were numerous in 1 HSS and 1 infantile NAD case. In addition, axonal spheroids were immunostained in all 6 cases of primary NAD, 5 cases of secondary NAD, and 2 cases of recent head injury. Axonal spheroids were faintly stained in the 3 physiologic NAD cases. Alpha-synuclein positive axonal swellings may suggest a mechanism, such as axonal injury, leading to the neuronal cytoplasmic accumulation of alpha-synuclein in NAD and other disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10604751     DOI: 10.1097/00005072-199912000-00007

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  42 in total

1.  Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology.

Authors:  J E Galvin; B Giasson; H I Hurtig; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Head injury, α-synuclein Rep1, and Parkinson's disease.

Authors:  Samuel M Goldman; Freya Kamel; G Webster Ross; Sarah A Jewell; Grace S Bhudhikanok; David Umbach; Connie Marras; Robert A Hauser; Joseph Jankovic; Stewart A Factor; Susan Bressman; Kelly E Lyons; Cheryl Meng; Monica Korell; Diana F Roucoux; Jane A Hoppin; Dale P Sandler; J William Langston; Caroline M Tanner
Journal:  Ann Neurol       Date:  2012-01       Impact factor: 10.422

3.  Many roads to Parkinson's disease neurodegeneration: head trauma-a road more traveled than we know?

Authors:  David J Irwin; John Q Trojanowski
Journal:  Mov Disord       Date:  2013-07-08       Impact factor: 10.338

Review 4.  Long-term consequences: effects on normal development profile after concussion.

Authors:  Daniel H Daneshvar; David O Riley; Christopher J Nowinski; Ann C McKee; Robert A Stern; Robert C Cantu
Journal:  Phys Med Rehabil Clin N Am       Date:  2011-09-23       Impact factor: 1.784

Review 5.  Pathological proteins in Parkinson's disease: focus on the proteasome.

Authors:  Heather Snyder; Benjamin Wolozin
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

6.  Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans.

Authors:  Kunihiro Uryu; Xiao-Han Chen; Dan Martinez; Kevin D Browne; Victoria E Johnson; David I Graham; Virginia M-Y Lee; John Q Trojanowski; Douglas H Smith
Journal:  Exp Neurol       Date:  2007-07-10       Impact factor: 5.330

7.  Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations.

Authors:  Ibrahim Malik; John Turk; David J Mancuso; Laura Montier; Mary Wohltmann; David F Wozniak; Robert E Schmidt; Richard W Gross; Paul T Kotzbauer
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

Review 8.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation.

Authors:  A Gregory; B J Polster; S J Hayflick
Journal:  J Med Genet       Date:  2008-11-03       Impact factor: 6.318

9.  Traumatic brain injury, paraquat exposure, and their relationship to Parkinson disease.

Authors:  Pei-Chen Lee; Yvette Bordelon; Jeff Bronstein; Beate Ritz
Journal:  Neurology       Date:  2012-11-13       Impact factor: 9.910

10.  Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity.

Authors:  Ming Tong; Matthew Dong; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.